Top Tweets for #bsAbs
Antibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Research Highlight -GB12-09, a bispecific antibody targeting IL4Rα and IL31Rα for atopic dermatitis therapy.
https://t.co/QmzSQbVTF1
#bispecificantibodies #bsab #bsabs #atopicdermatitis #th2cytokines #il4rα #il31rα
Top trending companies on X from @ASCO 2026 for BsAbs, curated by @LARVOL CLIN.
Explore more insights and conference data from #ASCO26 👉 https://t.co/7DT5JCwVFe
#LARVOL #ASCO2026 #CancerResearch #CancerData #Oncology #OncologyInsights #ClinicalTrials #ClinicalOncology #BsAbs | @DrRishabhOnco | @M_Torasawa | @DrChoueiri | @HHorinouchi | @SuyogCancer | @PTarantinoMD | @Erman_Akkus | @StephenVLiu | @HadidiSamer | @ADesaiMD
📚#二重特異性抗体（#Bispecific #Antibodies）
#BsAbs は2つの標的に同時に結合し、より高い精度、強力な治療効果、免疫細胞のリダイレクションを可能にします。本記事では、二重特異性抗体の基礎、がん治療への応用、そして新たな戦略を解説しています。
🔗 https://t.co/qLHzE9MLF6
#がん治療 #免疫療法
📚 今週のダイジェスト｜二重特異性抗体（#BsAbs）
BsAbsは、2つの標的に同時に結合できる抗体。
高い精度、強力な効果、免疫細胞リダイレクトなどの新しい作用機序により、がん治療で注目を集めています。
本記事では、BsAb研究の最新動向を紹介します：
✔️ 二重特異性抗体設計の基本原理
✔️ がん治療における役割の拡大
✔️ 次世代BsAbsを形作る新戦略
🔗 詳しくはこちら
https://t.co/YfCDSk96Ld
#二重特異性抗体 #がん治療 #免疫療法
#バイオ医薬品 #創薬 #ライフサイエンス
📚#Bispecific #Antibodies
#BsAbs bind two targets at once, enabling higher precision, stronger efficacy, and immune cell redirection. This article covers BsAb fundamentals, cancer applications, and emerging strategies.
🔗https://t.co/FnIJfRnyIA
#CancerTherapy #Immunotherapy
🔊 Exciting episode of SOHO Insider! Join me as we gain valuable insight from Dr. Tara Graff about operationalizing CAR T-cell therapy and bispecific antibodies (BsAbs) within the community.
#BsABS #CART #SOHOinsider
“Bispecifics are like a matchmaker… if it’s a perfect match, fireworks happen!” Dr. Graff said. Listen to our new podcast episode here: https://t.co/Nnpmf81sq1 @heMEGirl_MD
Thrilled to share our latest publication in @BloodAdvances! 📖✨
What happens after CAR T-cell therapy in LBCL? Our analysis explores outcomes with bispecific antibodies in the post CAR T-cell setting.
🧬 Read here: https://t.co/UGuswQiCzX
#Lymphoma #CARTcell #BsAbs
A look at BsAb trials in Gynecologic Cancer to be presented at @myESMO 2025.
Explore more insights and data from #ESMO25: https://t.co/cm6D8IcxgK
#LARVOL #GynecologicCancer #Gynecology #CancerResearch #CancerData #Oncology #OncologyInsights #BsAbs #ClinicalTrials #MedicalOncology | @DrKatyMoore | @pedroramirezMD | @leitaomd | @ShannonWestin | @agz_eriksson | @SuyogCancer
A look at BsAb trials in GI Cancer to be presented at @myESMO 2025.
Explore more insights and data from #ESMO25: https://t.co/cm6D8IcxgK
#LARVOL #GICancer #GastrointestinalCancer #CancerResearch #CancerData #Oncology #OncologyInsights #BsAbs #ClinicalTrials #MedicalOncology | @Erman_Akkus | @ArndtVogel | @GIMedOnc | @CathyEngMD | @GillSharlene | @SuyogCancer
A look at BsAb trials in Lung Cancer to be presented at @myESMO 2025.
Explore more insights and data from #ESMO25: https://t.co/cm6D8IcxgK
#LARVOL #LungCancer #CancerResearch #CancerData #Oncology #OncologyInsights #BsAbs #ClinicalTrials #MedicalOncology | @Tony_Calles | @HHorinouchi | @RManochakian | @FordePatrick | @StephenVLiu | @g_mountzios | @SuyogCancer
An overview of bispecific antibodies (BsAbs) marketed or in Phase 3 for non-small cell lung cancer 🫁.
🔗 Follow us for latest clinical trials and insights from the world of oncology 👉 https://t.co/MYJm2NGHs1
#LARVOL #LungCancer #NSCLC #BsAbs #WorldLungCancerDay #CancerResearch #Oncology #ClinicalTrials #CancerData #OncologyInsights #WLCD | @APassaroMD | @PatelOncology | @FordePatrick | @Tony_Calles | @BalazsHalmosMD | @DrSanjayPopat | @SuyogCancer
An overview of bispecific antibody (BsAbs) therapies in small cell lung cancer 🫁.
🔗 Follow us for latest clinical trials and insights from the world of oncology 👉 https://t.co/MYJm2NGHs1
#LARVOL #LungCancer #SCLC #BsAbs #WorldLungCancerDay #CancerResearch #Oncology #ClinicalTrials #CancerData #OncologyInsights #WLCD | @Alfdoc2 | @ADesaiMD | @DrJNaidoo | @HHorinouchi | @BalazsHalmosMD | @DrSanjayPopat | @SuyogCancer
Here's a look at the CLDN18.2-targeting Bispecific Antibody (BsAb) pipeline in GI cancers.
Explore more about oncology conferences, top trials, and reactions from oncologists: https://t.co/ct6tMIQ9sK
#LARVOL #GICancer #GastrointestinalCancer #BsAbs #Oncology #CancerResearch #CancerData #OncologyInsights | @rachnatshroff | @Erman_Akkus | @pashtoonkasi | @ilyassahinMD | @LizzySmyth1 | @YJanjigianMD | @SuyogCancer
On World Kidney Cancer Day, here’s an overview of the bispecific antibody (BsAb) pipeline in renal cell carcinoma.
Explore more about oncology conferences, top trials, and reactions from oncologists: https://t.co/ct6tMIQHii
#WorldKidneyCancerDay #RCC #Oncology #BsAbs #ClinicalTrials #Larvol #CancerData #CancerResearch | @montypal | @neerajaiims | @TiansterZhang | @nataliagandur | @MosheOrnsteinMD | @DrChoueiri | @tompowles1 | @SuyogCancer
Bispecific Antibodies data at @EHA_Hematology 2025: BCMA, GPRC5D, and dual-targeting approaches in myeloma and hematologic cancers.
Follow us for the latest #EHA2025 updates: https://t.co/GlFVhoEY2I
#LARVOL #BsAbs #Hematology #Myeloma #CancerResearch #Oncology #CancerData #OncologyInsights | @RahulBanerjeeMD | @HadidiSamer | @Rfonsi1 | @Mohty_EBMT | @ManniMD1 | @Abdallah81MD | @bdermanmd | @AaronGoodman33 | @graham74GC | @tobyeyre82 | @majorajay | @DrRaulCordoba | @Eddie_Cliff | @smbenlazar | @SuyogCance
@IMG_Oncologists
Thrilled to be part of #ASCO2025, contributing to six posters—including one as first author! #OnlinePublication #BsAbs #SolidTumors
Grateful to @ADesaiMD for your outstanding mentorship & this incredible opportunity. It was a pleasure collaborating with @Larvol.
TIGIT-based BsAbs early phase studies are to be presented at @ASCO 2025.
Catch every #ASCO25 update as it drops: https://t.co/1AuNSQx3PR
#LARVOL #ASCO2025 #BsAbs #TIGIT #CancerResearch #Oncology #ClinicalTrials #CancerData #OncologyInsights | @rachnatshroff | @ilyassahinMD | @VivekSubbiah | @leitaomd | @nicoleflemingmd | @BatistaTP | @CathyEngMD | @SuyogCancer
TIGIT Gets Tactical: Bispecific Antibodies (BsAbs) Redefining Immune Checkpoint Blockade. Focus on TIGIT BsAbs at @ASCO 2025.
Never miss an update about #ASCO25 with us: https://t.co/051z3BNE4z
#LARVOL #BsAbs #TIGIT #CancerResearch #Oncology #OncologyInsights #CancerData #ClinicalTrials | @DrRiyazShah | @DrSanjayPopat | @RManochakian | @g_mountzios | @CharuAggarwalMD | @Dr_Ivanoncologo | @ShannonWestin | @SuyogCancer | @YJanjigianMD
Last Seen Hashtags on Sotwe
xlii or #exny or #nolimit() #momson() +filter:native_video
Seen from France
FoodCaring
Seen from United States
射精
Seen from United States
TechnoIs
Seen from United States
VersículoDoDia
Seen from Indonesia
indian #chut
Seen from India
thebostabrasil
Seen from United States
ESASB
Seen from United States
yujirohanma
Seen from France
Dharmraj_Saini
Seen from United States
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.8M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111.4M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.8M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.1M followers
Taylor Swift
@taylorswift13
81.9M followers
Lady Gaga
@ladygaga
73.5M followers
Virat Kohli
@imvkohli
70.5M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.1M followers
Neymar Jr
@neymarjr
63.4M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61.1M followers
X
@x
60.8M followers